Vitamin D deficiency in postmenopausal breast cancer survivors

Journal of Women's Health

Volumn 21, Issue 4, 2012, Pages 456-462

  Friedman, Claire F ^a   DeMichele, Angela ^a   Su, H Irene ^b   Feng, Rui ^a   Kapoor, Shiv ^a   Desai, Krupali ^a   Mao, Jun J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; VITAMIN D;

ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURVIVOR; CAUCASIAN; CROSS-SECTIONAL STUDY; ETHNICITY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; OBESITY; PRIORITY JOURNAL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

BREAST NEOPLASMS; FEMALE; HUMANS; QUESTIONNAIRES; SURVIVORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84859788187     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2011.3009     Document Type: Article

References (41)

1. Tangpricha V, Pearce E, Chen T, Holick M. Vitamin D insufficiency among free-living healthy young adults. Am J Med 2002;112:659-662. (Pubitemid 34597167)
2. Lips P, Duong T, Oleksik A, et al. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: Baseline data from the Multiple Outcomes of Raloxifene Evaluation Clinical Trial. J Clin Endocrinol Metab 2001;86:1212-1221. (Pubitemid 32323007)
3. Nesby-O'Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: Third National Health and Nutrition Examination Survey, 1988- 1994. Am J Clin Nutr 2002;76:187-192. (Pubitemid 34686565)
4. Goodwin PJ, Ennis M, Pritchard KI, Koo J, Hood N. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin Oncol 2009;27:3757-3763.
5. Freedman DM, Chang SC, Falk RT, et al. Serum levels of vitamin D metabolites and breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 2008;17:889-894. (Pubitemid 351536420)
6. Chen Z, Maricic M, Bassford TL, et al. Fracture risk among breast cancer survivors: Results from the Women's Health Initiative Observational Study. Arch Intern Med 2005;165: 552-558. (Pubitemid 40344388)
7. Bischoff-Ferrari HA, Giovannucci E, Wilett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84:18-28. (Pubitemid 44699167)
8. Jackson RD, LaCroix AZ, Gass M, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med, 2006;354:669-683. (Pubitemid 43247138)
9. Robbins J. High-dose oral vitamin D supplements and active vitamin D prevent falls in older persons. Ann Intern Med 2010;152:JC1-3.
10. Waltman NL, Ott CD, Twiss JJ, Gross GJ, Lindsey AM. Vitamin D insufficiency and musculoskeletal symptoms in breast cancer survivors on aromatase inhibitor therapy. Cancer Nurs 2009;32:143-150
11. Khan QJ, Reddy PS, Kimler BF, et al. Effect of vitamin D supplmentation on serum 25-hydroxyvitamin D levels, joint pain and fatigue in women starting adjuvant letrozole treatment for breast cancer. Breast Cancer Res Treat 2009 119:111-118.
12. Colston KW, Hansen CM. Mechanisms implicated in the growth regulatory effects of vitamin D in breast cancer. Endocr Relat Cancer 2002;9:45-59. (Pubitemid 34298363)
13. Nagpal S, Na S, Rathnachalam R. Noncalcemic actions of vitamin D receptor ligands. Endocr Rev 2005;26:662-687. (Pubitemid 41127276)
14. Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE. 1-Alpha,25-dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo. Circ Res 2000;87:214-220. (Pubitemid 30626429)
15. Trump DL, Muindi J, Fakih M, Yu WD, Johnson CS. Vitamin D compounds: Clinical development as cancer therapy and prevention agents. Anticancer Res 2006;26:2551-2556. (Pubitemid 44155534)
16. Gombart AF, Luong QT, Koeffler HP. Vitamin D compounds: Activity against microbes and cancer. Anticancer Res 2006;26 2531-2542. (Pubitemid 44155532)
17. Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahyoun NR. Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 2002;30:771-777. (Pubitemid 34468001)
18. Cheng S, Massaro JM, Fox CS, et al. Adiposity, cardiometabolic risk, and vitamin D status: The Framingham Heart Study. Diabetes 2010;59:242-248.
19. Zadshir A, Tareen N, Pan D, Norris K, Martins D. The prevalence of hypovitaminosis D among U.S. adults: Data from the NHANES III. Ethnicity Dis 2005;15:S5-97-101.
20. Crew KD, Shane E, Cremers S, McMahon DJ, Irani D, Hershman DL. High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol 2009;27:2151-2156.
21. Hollis BW. Quantitation of 25-hydroxyvitamin D and 1,25- dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers. Methods Enzymol 1997;282:174-186. (Pubitemid 27412774)
22. Wang-Gillam A, Miles DA, Hutchins LF. Evaluation of vitamin D deficiency in breast cancer patients on bisphosphonates. Oncologist 2008;13:821-827.
23. Palmieri C, MacGregor T, Girgis S, Vigushin D. Serum 25- hydroxyvitamin D levels in early and advanced breast cancer. J Clin Pathol 2006;59:1334-1336. (Pubitemid 46048345)
24. Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: The National Academies Press, 2011.
25. Chan J, Jaceldo-Siegl K, Fraser G. Determinants of serum 25 hydroxyvitamin D levels in a nationwide cohort of blacks and non-Hispanic whites. Cancer Causes Control 2010;21: 501-511.
26. Egan KM, Signorello LB, Munro HM, Hargreaves MK, Hollis BW, Blot WJ. Vitamin D insufficiency among African- Americans in the southeastern United States: Implications for cancer disparities (United States). Cancer Causes Control 2008;19:527-535
27. McKinney K, Breitkopf CR, Berenson AB. Association of race, body fat and season with vitamin D status among young women: A cross-sectional study. Clin Endocrinol 2008;69:535-541.
28. Clemens TL, Adams JS, Henderson SL, Holick MF. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet 1982;319:74-76. (Pubitemid 12248649)
29. Johnson MA, Kimlin MG. Vitamin D, aging, and the 2005 Dietary Guidelines for Americans. Nutr Rev 2006;64: 410-421. (Pubitemid 44525200)
30. Talwar SA, Aloia JF, Pollack S, Yeh JK. Dose response to vitamin D supplementation among postmenopausal African American women. Am J Clin Nutr 2007;86:1657-1662 (Pubitemid 350232180)
31. Compston JE, Vedi S, Ledger JE, Webb A, Gazet JC, Pikington TR. Vitamin D status and bone histomorphometry in gross obesity. Am J Clin Nutr 1981;34:2359-2363. (Pubitemid 12176062)
32. Lagunova Z, Porojnicu AC, Lindberg F, Hexeberg S, Moan J. The dependency of vitamin D status on body mass index, gender, age and season. Anticancer Res 2009;29:3713-3720
33. Looker AC. Body fat and vitamin D status in black versus white women. J Clin Endocrinol Metab 2005;90:635-640 (Pubitemid 40279173)
34. Mawer EB, Backhouse J, Holman CA, Lumb GA, Stanbury SW. The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci 1972;43:413-431.
35. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-693. (Pubitemid 30667088)
36. Majed B, Moreau T, Senouci K, Salmon RJ, Fourquet A, Asselain B. Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat 2008;111: 329-342.
37. Lee P, Greenfield JR, Seibel MJ, Eisman JA, Center JR. Adequacy of vitamin D replacement in severe deficiency is dependent on body mass index. Am J Med 2009;122: 1056-1060.
38. Eastell R, Adams JE, Coleman RE, et al. Effect of anastrozole on bone mineral density: 5-Year results from the Anastrozole, tamoxifen, Alone or in Combination Trial 18233230. J Clin Oncol 2008;26:1051-1057.
39. Vestergaard P, Rejnmark L, Mosekilde L. Effect of tamoxifen and aromatase inhibitors on the risk of fractures in women with breast cancer. Calcif Tissue Int 2008;82:334-340
40. Bergman G, Fan T, McFetridge JT, Sen SS. Efficacy of vitamin D(3) supplementation in preventing fractures in elderly women: A meta-analysis. Curr Med Res Opin 2010;26: 1193-1201.
41. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: A meta-analysis of randomized controlled trials. JAMA 2005;293:2257-2264. (Pubitemid 40629192)